Meloxicam vs. Ibuprofen for Pain Control After Wisdom Tooth Removal
meloxicam 7,5mg
Facial Pain+7
+ Stomatognathic Diseases
+ Nervous System Diseases
Treatment Study
Summary
Study start date: December 15, 2024
Actual date on which the first participant was enrolled.This clinical trial aims to compare the effectiveness of two common pain relief medications, meloxicam and ibuprofen, for managing pain after the removal of wisdom teeth in adults. Wisdom tooth extraction often causes pain and swelling, making it important to find the most effective medication for easing these symptoms and ensuring a smoother recovery. Both meloxicam and ibuprofen are non-steroidal anti-inflammatory drugs (NSAIDs) known for treating mild to moderate postoperative pain. The study seeks to determine which of these drugs offers better pain control following this common dental procedure. Participants in the study will be randomly assigned to receive either meloxicam (7.5 mg) or ibuprofen (400 mg) after their wisdom teeth are removed. The study follows a strict design to ensure reliable results, with neither the participants nor the researchers knowing which medication is being taken by each participant. The effectiveness of each drug will be evaluated based on how well it manages pain after the surgery. This research could help dental professionals make informed decisions about the best pain management strategies for their patients following tooth extractions.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.68 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 59 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Maxillary or mandibular third molar with semi or fully erupted crown. Exclusion Criteria: Patients with Systemic pathologies. Presence of third molar localized infection. Completely included third molar crown. Periodontal compromise. Pregnant or breastfeeding women. Patients with hypersensitivity to NSAIDs. Patients with a history of drug abuse. Patients who had taken any drug in the previous 24 hours. Intervention (exodontia) time longer than 45 minutes.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorStudy Objectives
Primary Objectives